Clinical Trials Logo

Filter by:
NCT ID: NCT01257984 Completed - Contraception Clinical Trials

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The objective of the study is to evaluate the effect of the dispenser's buzzer function on compliance with daily tablet intake of an ethinyl estradiol (EE) + drospirenone (DRSP) containing oral contraceptive (OC) in a flexible extended regimen when administered for approximately 12 months to healthy female volunteers who request contraception.

NCT ID: NCT01257776 Completed - Diabetes Clinical Trials

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

Start date: December 2010
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective, multicenter, open, randomized, parallel-group controlled study for two levels of dose. The study population will consist of 30 non-diabetic patients with critical chronic ischemia in at least one of the lower limbs (CLI) and without possibility of revascularization, from whom results can clinically be evaluable, of whom, 20 patients will be included in the experimental group (10 for each dose level) and 10 in the control group. In each of the two dose levels to be used in the study, 15 patients will be included, who will be randomized to the experimental group or the control group according to a distribution 2:1 (2 patients in the experimental group and 1 in control group), thus at each dose level, we will have 10 patients in the experimental group (treated with mesenchymal cells of adipose tissue) and 5 patients in the control group (conventional treatment)

NCT ID: NCT01257451 Completed - Clinical trials for Type 2 Diabetes Mellitus

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Start date: December 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of vildagliptin 50 mg bid in elderly patients with Type 2 Diabetes Mellitus (T2DM).

NCT ID: NCT01257230 Completed - Asthma Clinical Trials

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The aim of the study is to evaluate efficacy and safety of a 48-week treatment with two doses of tiotropium bromide compared to placebo in adolescent patients with moderate persistent asthma. Efficacy and safety will be assessed by measuring lung function parameters and evaluating the effects on asthma exacerbations, on Quality of life, on health care resource utilisation an on the number of adverse events.

NCT ID: NCT01255982 Completed - Bipolar Disorder Clinical Trials

Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up

Start date: March 2011
Phase: N/A
Study type: Observational

This study aims to study prospectively for 8 months a sample of bipolar patients with acute depressive episode in order to identify that factors associated with functional impairment, with especial attention to the presence of subsyndromal symptoms beyond the acute phase.

NCT ID: NCT01255813 Completed - Clinical trials for Chronic Cluster Headache

Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache

Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of the proposed clinical study is to evaluate the use of an implanted Neurostimulator to provide Sphenopalatine Ganglion (SPG) stimulation for the management of the pain associated with cluster headaches.

NCT ID: NCT01255722 Completed - Clinical trials for Coronary Artery Disease

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

X-ACT
Start date: November 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate the (statistical) non-inferiority of iobitridol (Xenetix® 350) when compared to contrast agents with higher iodine concentrations, iopromide (Ultravist® 370) and iomeprol (Iomeron® 400) in terms of coronary CT scan evaluability (quality and interpretability of images).

NCT ID: NCT01254539 Completed - Clinical trials for Amyotrophic Lateral Sclerosis

Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA)

Start date: October 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this clinical trial is to assess the feasibility and the security of the intraspinal and intrathecal infusion of autologous bone marrow stem cells for the treatment of Amyotrophic Lateral Sclerosis patients.

NCT ID: NCT01254487 Completed - Clinical trials for Coronary Artery Disease

e-BioMatrix PostMarket Surveillance Registry

Start date: March 2008
Phase:
Study type: Observational

The purpose of the e-BioMatrix PMS registry is to capture clinical data of the BioMatrix (Biolimus A9-Eluting) stent system in relation to safety and effectiveness.

NCT ID: NCT01254279 Completed - Clinical trials for Prostate Cancer Metastatic

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to allow patients similar to that evaluated in the TROPIC trial (NCT00417079), and Investigators access to cabazitaxel for the management of metastatic Hormone Refractory Prostate Cancer (mHRPC) in those patients who have progressed during or after docetaxel and to document the overall safety of cabazitaxel in these patients. Please note that in each country, patient recruitment will end when cabazitaxel becomes commercially available.